Stocks In News - USFDA

1. Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Solifenacin Succinate tablets, 5 mg and 10 mg, which is a generic version of Vesicare tablets, 5 mg and 10 mg of Astellas Pharma US Inc,.
2. The Vesicare tablets achieved annual sales of approximately USD 1.1 billion for the 12 month period ending April 2017.
3. The company's current portfolio consists of 117 products authorized for distribution in the US market place and 68 ANDA’s pending approval with the USFDA.